应用扩散峰度成像技术表征脑脊液的非高斯扩散特性并探讨其对阿尔茨海默病的诊断价值
Characterize the non-Gaussian diffusion property of cerebrospinal fluid using Diffusion Kurtosis Imaging and explore its diagnostic efficacy for Alzheimer's disease
摘要:
区分阿尔茨海默病(AD)患者与健康对照(HC)仍然是一个挑战。AD患者脑脊液蛋白水平的变化已有文献报道。大分子会阻碍脑脊液中水分的运动,导致非高斯扩散。扩散峰度成像(DKI)是用于量化非高斯扩散率的常用技术。在这项研究中,我们使用DKI来评估AD患者和HC的CSF的非高斯扩散。探索组间差异。此外,我们使用交叉验证支持向量机(SVM)建立了预测模型,并取得了良好的性能。验证的受试者工作特征曲线下面积(AUC)在0.96-1.00范围内,正确预测率在87.1% -90.0%范围内。
英文摘要:
Differentiating Alzheimer's disease (AD) patients from healthy controls (HCs) remains a challenge. The changes of protein level in cerebrospinal fluid (CSF) of AD patients have been reported in the literature. Macromolecules will hinder the movement of water in CSF and lead to non-Gaussian diffusion. Diffusion kurtosis imaging (DKI) is a commonly used technique for quantifying non-Gaussian diffusivity. In this study, we used DKI to evaluate the non-Gaussian diffusion of CSF in AD patients and HC. Between-group difference was explored. In addition, we have built a prediction model using cross-validation Support Vector Machines (SVM), and achieved excellent performance. The validated area under the receiver operating characteristic curve(AUC) is in the range of 0.96-1.00, and the correct prediction is in the range of 87.1% - 90.0%.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。